Diagnostic value of gadobenate dimeglumine-enhanced hepatocyte-phase magnetic resonance imaging in evaluating hepatic fibrosis and hepatitis

doi:10.3748/wjg.v23.i17.3133

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 23, Issue 17

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7056)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-5) series, Tables (1-6) series.

Item

Count

PDF

522

WORD

289

HTML

3382

Figures (1-5)

251

Tables (1-6)

162

Sum=4606

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

979

Download

1468

Sum=2447

May 7, 2017 (publication date) through Jul 21, 2024

Times Cited of This Article

Times Cited (7)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical Trials Study

World J Gastroenterol. May 7, 2017; 23(17): 3133-3141
Published online May 7, 2017. doi: 10.3748/wjg.v23.i17.3133

Table 5 Relative enhancement ratio in the hepatocyte phase in the five grades of hepatitis

Grade	REh (mean ± standard)	Minimum value	Maximum value
G1 (n = 44)	0.505 ± 0.194	0.129	1.006
G2 (n = 22)	0.402 ± 0.190	0.033	0.836
G3 (n = 8)	0.428 ± 0.147	0.182	0.621
G4 (n = 2)	0.209 ± 0.170	0.197	0.221

REh: Relative enhancement ratio in the hepatocyte phase.

Citation: Li XM, Chen Z, Xiao EH, Shang QL, Ma C. Diagnostic value of gadobenate dimeglumine-enhanced hepatocyte-phase magnetic resonance imaging in evaluating hepatic fibrosis and hepatitis. World J Gastroenterol 2017; 23(17): 3133-3141
URL: https://www.wjgnet.com/1007-9327/full/v23/i17/3133.htm
DOI: https://dx.doi.org/10.3748/wjg.v23.i17.3133